NYSE · BMEZ · USD
Stock price, dividends
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BlackRock Health Sciences Term Trust’s quoted price sits in the upper half of its reported 52-week range, 0.34% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BlackRock Health Sciences Term Trust’s forward annual dividend is $1.32 per share, paid monthly. The forward yield is 7.42% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:07 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$18.94+$0.02 (+0.11%)
Schwab Target 2030 Index Fund Institutional Shares’s quoted price sits in the upper half of its reported 52-week range, 1.61% below the high.
$9.69+$0.12 (+1.25%)
BlackRock Enhanced Equity Dividend Trust’s quoted price sits in the upper half of its reported 52-week range, 2.61% below the high.
$48.90-$0.31 (-0.63%)
BlackRock Science and Technology Trust’s quoted price sits in the upper half of its reported 52-week range, 6.54% below the high.
$35.93-$0.06 (-0.17%)
Victory Portfolios III - Victory World Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 2.12% below the high.
$22.62-$0.06 (-0.26%)
Franklin Growth Allocation R’s quoted price sits in the upper half of its reported 52-week range, 3.21% below the high.
$25.41+$0.19 (+0.75%)
Fidelity Advisor Dividend Growth Z’s quoted price sits in the upper half of its reported 52-week range, 5.15% below the high.
$13.81+$0.25 (+1.84%)
BlackRock Capital Allocation Trust’s quoted price sits in the lower half of its reported 52-week range, 14.75% below the high.
$22.22+$0.09 (+0.41%)
Blackrock Municipal 2030 Target Term Trust’s quoted price sits in the lower half of its reported 52-week range, 4.39% below the high.
